User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.

Primary tabs

download
  • Open access
  • PDF
  • 1.30 M
Delzenne, Nathalie M. [UCL] Knudsen, Christelle [UCL] Beaumont, Martin [UCL] Rodriguez, Julie [UCL] Neyrinck, Audrey M. [UCL] Bindels, Laure B. [UCL]

This review presents mechanistic studies performed in vitro and in animal models, as well as data obtained in patients that contribute to a better understanding of the impact of nutrients interacting with the gut microbiota on metabolic and behavioural alterations linked to obesity. The gut microbiota composition and function are altered in several pathological conditions including obesity and related diseases i.e. non-alcoholic fatty liver diseases (NAFLD). The gut-liver axis is clearly influenced by alterations of the gut barrier that drives inflammation. In addition, recent papers propose that specific metabolites issued from the metabolic cooperation between the gut microbes and host enzymes, modulate inflammation and gene expression in the liver. This review illustrates how dietary intervention with prebiotics or probiotics influences host energy metabolism and inflammation. Indeed, intervention studies are currently underway in obese and NAFLD patients to unravel the relevance of the changes in gut microbiota composition in the management of metabolic and behavioural disorders by nutrients interacting with the gut microbiota. In conclusion, diet is among the main triggers of NAFLD and the gut microbiota is modified accordingly, underlining the importance of the concomitant study of the nutrients and microbial impact on liver health and metabolism, in order to propose innovative, clinically relevant, therapeutic approaches.

Document type Article de périodique (Journal article) – Synthèse de littérature
Access type Accès libre
Publication date 2019
Language Anglais
Journal information "The Proceedings of the Nutrition Society" - Vol. 78, no. 3, p. 319-328 (2019)
Peer reviewed yes
Publisher Published on behalf of the Nutrition Society by CABI Publishing ((United Kingdom) Wallingford)
issn 0029-6651
e-issn 1475-2719
Publication status Publié
Affiliation UCL - SSS/LDRI - Louvain Drug Research Institute
Keywords ALT alanine aminotransferase ; AST aspartate aminotransferase ; AhR aryl hydrocarbon receptor ; BA bile acid ; FXR farnesoid X receptor ; GLP glucagon-like peptide ; GPR G protein-coupled receptors ; ITF inulin-type fructans ; LPS lipopolysaccharides ; NAFLD non-alcoholic fatty liver disease ; NASH non-alcoholic steatohepatitis ; Gut microbiota ; Inflammation ; Non-alcoholic fatty liver disease ; Prebiotics
Links
  1. Maruvada Padma, Leone Vanessa, Kaplan Lee M., Chang Eugene B., The Human Microbiome and Obesity: Moving beyond Associations, 10.1016/j.chom.2017.10.005
  2. Perumpail Brandon J, Khan Muhammad Ali, Yoo Eric R, Cholankeril George, Kim Donghee, Ahmed Aijaz, Clinical epidemiology and disease burden of nonalcoholic fatty liver disease, 10.3748/wjg.v23.i47.8263
  3. Torres-Fuentes Cristina, Schellekens Harriët, Dinan Timothy G, Cryan John F, The microbiota–gut–brain axis in obesity, 10.1016/s2468-1253(17)30147-4
  4. Cotillard Aurélie, , Kennedy Sean P., Kong Ling Chun, Prifti Edi, Pons Nicolas, Le Chatelier Emmanuelle, Almeida Mathieu, Quinquis Benoit, Levenez Florence, Galleron Nathalie, Gougis Sophie, Rizkalla Salwa, Batto Jean-Michel, Renault Pierre, Doré Joel, Zucker Jean-Daniel, Clément Karine, Ehrlich Stanislav Dusko, , Dietary intervention impact on gut microbial gene richness, 10.1038/nature12480
  5. Cani P. D., Bibiloni R., Knauf C., Waget A., Neyrinck A. M., Delzenne N. M., Burcelin R., Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice, 10.2337/db07-1403
  6. Brandl Katharina, Kumar Vipin, Eckmann Lars, Gut-liver axis at the frontier of host-microbial interactions, 10.1152/ajpgi.00361.2016
  7. Husted Anna Sofie, Trauelsen Mette, Rudenko Olga, Hjorth Siv A., Schwartz Thue W., GPCR-Mediated Signaling of Metabolites, 10.1016/j.cmet.2017.03.008
  8. Hubbard T. D., Murray I. A., Perdew G. H., Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation, 10.1124/dmd.115.064246
  9. Krishnan Smitha, Ding Yufang, Saedi Nima, Choi Maria, Sridharan Gautham V., Sherr David H., Yarmush Martin L., Alaniz Robert C., Jayaraman Arul, Lee Kyongbum, Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages, 10.1016/j.celrep.2018.03.109
  10. Cani Patrice D., Osto Melania, Geurts Lucie, Everard Amandine, Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity, 10.4161/gmic.19625
  11. Cani P. D., Amar J., Iglesias M. A., Poggi M., Knauf C., Bastelica D., Neyrinck A. M., Fava F., Tuohy K. M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.-F., Gibson G. R., Casteilla L., Delzenne N. M., Alessi M. C., Burcelin R., Metabolic Endotoxemia Initiates Obesity and Insulin Resistance, 10.2337/db06-1491
  12. Cani P. D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D. M., Muccioli G. G., Delzenne N. M., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, 10.1136/gut.2008.165886
  13. Neyrinck A M, Van Hée V F, Piront N, De Backer F, Toussaint O, Cani P D, Delzenne N M, Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice, 10.1038/nutd.2011.24
  14. Al-Attas Omar S, Al-Daghri Nasser M, Al-Rubeaan Khalid, da Silva Nancy F, Sabico Shaun L, Kumar Sudhesh, McTernan Philip G, Harte Alison L, Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies, 10.1186/1475-2840-8-20
  15. Galic Sandra, Oakhill Jon S., Steinberg Gregory R., Adipose tissue as an endocrine organ, 10.1016/j.mce.2009.08.018
  16. Tilg Herbert, Moschen Alexander R, Microbiota and diabetes: an evolving relationship, 10.1136/gutjnl-2014-306928
  17. Le Chatelier Emmanuelle, , Nielsen Trine, Qin Junjie, Prifti Edi, Hildebrand Falk, Falony Gwen, Almeida Mathieu, Arumugam Manimozhiyan, Batto Jean-Michel, Kennedy Sean, Leonard Pierre, Li Junhua, Burgdorf Kristoffer, Grarup Niels, Jørgensen Torben, Brandslund Ivan, Nielsen Henrik Bjørn, Juncker Agnieszka S., Bertalan Marcelo, Levenez Florence, Pons Nicolas, Rasmussen Simon, Sunagawa Shinichi, Tap Julien, Tims Sebastian, Zoetendal Erwin G., Brunak Søren, Clément Karine, Doré Joël, Kleerebezem Michiel, Kristiansen Karsten, Renault Pierre, Sicheritz-Ponten Thomas, de Vos Willem M., Zucker Jean-Daniel, Raes Jeroen, Hansen Torben, Bork Peer, Wang Jun, Ehrlich S. Dusko, Pedersen Oluf, Richness of human gut microbiome correlates with metabolic markers, 10.1038/nature12506
  18. Furet J.-P., Kong L.-C., Tap J., Poitou C., Basdevant A., Bouillot J.-L., Mariat D., Corthier G., Dore J., Henegar C., Rizkalla S., Clement K., Differential Adaptation of Human Gut Microbiota to Bariatric Surgery-Induced Weight Loss: Links With Metabolic and Low-Grade Inflammation Markers, 10.2337/db10-0253
  19. Int J Endocrinol, 2018, 9 (2018)
  20. Everard A., Belzer C., Geurts L., Ouwerkerk J. P., Druart C., Bindels L. B., Guiot Y., Derrien M., Muccioli G. G., Delzenne N. M., de Vos W. M., Cani P. D., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, 10.1073/pnas.1219451110
  21. Plovier Hubert, Everard Amandine, Druart Céline, Depommier Clara, Van Hul Matthias, Geurts Lucie, Chilloux Julien, Ottman Noora, Duparc Thibaut, Lichtenstein Laeticia, Myridakis Antonis, Delzenne Nathalie M, Klievink Judith, Bhattacharjee Arnab, van der Ark Kees C H, Aalvink Steven, Martinez Laurent O, Dumas Marc-Emmanuel, Maiter Dominique, Loumaye Audrey, Hermans Michel P, Thissen Jean-Paul, Belzer Clara, de Vos Willem M, Cani Patrice D, A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, 10.1038/nm.4236
  22. Annual Review of Physiology, 78, 181 (2016)
  23. Tilg Herbert, Cani Patrice D, Mayer Emeran A, Gut microbiome and liver diseases, 10.1136/gutjnl-2016-312729
  24. Abdou Reham M., Zhu Lixin, Baker Robert D., Baker Susan S., Gut Microbiota of Nonalcoholic Fatty Liver Disease, 10.1007/s10620-016-4045-1
  25. Duarte S.M.B., Stefano J.T., Miele L., Ponziani F.R., Souza-Basqueira M., Okada L.S.R.R., de Barros Costa F.G., Toda K., Mazo D.F.C., Sabino E.C., Carrilho F.J., Gasbarrini A., Oliveira C.P., Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study, 10.1016/j.numecd.2017.10.014
  26. Le Roy Tiphaine, Llopis Marta, Lepage Patricia, Bruneau Aurélia, Rabot Sylvie, Bevilacqua Claudia, Martin Patrice, Philippe Catherine, Walker Francine, Bado André, Perlemuter Gabriel, Cassard-Doulcier Anne-Marie, Gérard Philippe, Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice, 10.1136/gutjnl-2012-303816
  27. Miele Luca, Valenza Venanzio, La Torre Giuseppe, Montalto Massimo, Cammarota Giovanni, Ricci Riccardo, Mascianà Roberta, Forgione Alessandra, Gabrieli Maria L., Perotti Germano, Vecchio Fabio M., Rapaccini Gianlodovico, Gasbarrini Giovanni, Day Chris P., Grieco Antonio, Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease, 10.1002/hep.22848
  28. Henao-Mejia Jorge, Elinav Eran, Jin Chengcheng, Hao Liming, Mehal Wajahat Z., Strowig Till, Thaiss Christoph A., Kau Andrew L., Eisenbarth Stephanie C., Jurczak Michael J., Camporez Joao-Paulo, Shulman Gerald I., Gordon Jeffrey I., Hoffman Hal M., Flavell Richard A., Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity, 10.1038/nature10809
  29. Bashiardes Stavros, Shapiro Hagit, Rozin Shachar, Shibolet Oren, Elinav Eran, Non-alcoholic fatty liver and the gut microbiota, 10.1016/j.molmet.2016.06.003
  30. Da Silva Hannah E., Teterina Anastasia, Comelli Elena M., Taibi Amel, Arendt Bianca M., Fischer Sandra E., Lou Wendy, Allard Johane P., Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance, 10.1038/s41598-018-19753-9
  31. Jiang Weiwei, Wu Na, Wang Xuemei, Chi Yujing, Zhang Yuanyuan, Qiu Xinyun, Hu Ying, Li Jing, Liu Yulan, Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease, 10.1038/srep08096
  32. Wong Vincent Wai-Sun, Tse Chi-Hang, Lam Tommy Tsan-Yuk, Wong Grace Lai-Hung, Chim Angel Mei-Ling, Chu Winnie Chiu-Wing, Yeung David Ka-Wai, Law Patrick Tik-Wan, Kwan Hoi-Shan, Yu Jun, Sung Joseph Jao-Yiu, Chan Henry Lik-Yuen, Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study, 10.1371/journal.pone.0062885
  33. Zhu Lixin, Baker Susan S., Gill Chelsea, Liu Wensheng, Alkhouri Razan, Baker Robert D., Gill Steven R., Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH, 10.1002/hep.26093
  34. Boursier Jérôme, Mueller Olaf, Barret Matthieu, Machado Mariana, Fizanne Lionel, Araujo-Perez Felix, Guy Cynthia D., Seed Patrick C., Rawls John F., David Lawrence A., Hunault Gilles, Oberti Frédéric, Calès Paul, Diehl Anna Mae, The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota : Boursier et al., 10.1002/hep.28356
  35. Hoyles Lesley, Fernández-Real José-Manuel, Federici Massimo, Serino Matteo, Abbott James, Charpentier Julie, Heymes Christophe, Luque Jèssica Latorre, Anthony Elodie, Barton Richard H., Chilloux Julien, Myridakis Antonis, Martinez-Gili Laura, Moreno-Navarrete José Maria, Benhamed Fadila, Azalbert Vincent, Blasco-Baque Vincent, Puig Josep, Xifra Gemma, Ricart Wifredo, Tomlinson Christopher, Woodbridge Mark, Cardellini Marina, Davato Francesca, Cardolini Iris, Porzio Ottavia, Gentileschi Paolo, Lopez Frédéric, Foufelle Fabienne, Butcher Sarah A., Holmes Elaine, Nicholson Jeremy K., Postic Catherine, Burcelin Rémy, Dumas Marc-Emmanuel, Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women, 10.1038/s41591-018-0061-3
  36. Shen Feng, Zheng Rui-Dan, Sun Xing-Qiang, Ding Wen-Jin, Wang Xiao-Ying, Fan Jian-Gao, Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease, 10.1016/s1499-3872(17)60019-5
  37. FEMS Microbiol Ecol, 91, 1 (2015)
  38. Raman Maitreyi, Ahmed Iftikhar, Gillevet Patrick M., Probert Chris S., Ratcliffe Norman M., Smith Steve, Greenwood Rosemary, Sikaroodi Masoumeh, Lam Victor, Crotty Pam, Bailey Jennifer, Myers Robert P., Rioux Kevin P., Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease, 10.1016/j.cgh.2013.02.015
  39. Postler Thomas Siegmund, Ghosh Sankar, Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System, 10.1016/j.cmet.2017.05.008
  40. Ridlon Jason M., Kang Dae-Joong, Hylemon Phillip B., Bile salt biotransformations by human intestinal bacteria, 10.1194/jlr.r500013-jlr200
  41. Leung Christopher, Rivera Leni, Furness John B., Angus Peter W., The role of the gut microbiota in NAFLD, 10.1038/nrgastro.2016.85
  42. Nyangale Edna. P., Mottram Donald. S., Gibson Glenn. R., Gut Microbial Activity, Implications for Health and Disease: The Potential Role of Metabolite Analysis, 10.1021/pr300637d
  43. Boets Eef, Deroover Lise, Houben Els, Vermeulen Karen, Gomand Sara, Delcour Jan, Verbeke Kristin, Quantification of in Vivo Colonic Short Chain Fatty Acid Production from Inulin, 10.3390/nu7115440
  44. Wong Julia M. W., de Souza Russell, Kendall Cyril W. C., Emam Azadeh, Jenkins David J. A., Colonic Health: Fermentation and Short Chain Fatty Acids : , 10.1097/00004836-200603000-00015
  45. Nicholson J. K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S., Host-Gut Microbiota Metabolic Interactions, 10.1126/science.1223813
  46. Wright R. S., Anderson J. W., Bridges S. R., Propionate Inhibits Hepatocyte Lipid Synthesis, 10.3181/00379727-195-43113
  47. Demigné Christian, Morand Christine, Levrat Marie-Anne, Besson Catherine, Moundras Corinne, Rémésy Christian, Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes, 10.1079/bjn19950124
  48. Svegliati-Baroni Gianluca, Saccomanno Stefania, Rychlicki Chiara, Agostinelli Laura, De Minicis Samuele, Candelaresi Cinzia, Faraci Graziella, Pacetti Deborah, Vivarelli Marco, Nicolini Daniele, Garelli Paolo, Casini Alessandro, Manco Melania, Mingrone Geltrude, Risaliti Andrea, Frega Giuseppe N., Benedetti Antonio, Gastaldelli Amalia, Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis : Effect of exenatide on the liver, 10.1111/j.1478-3231.2011.02462.x
  49. Bindels Laure B., Dewulf Evelyne M., Delzenne Nathalie M., GPR43/FFA2: physiopathological relevance and therapeutic prospects, 10.1016/j.tips.2013.02.002
  50. Bjursell Mikael, Admyre Therése, Göransson Melker, Marley Anna E., Smith David M., Oscarsson Jan, Bohlooly-Y Mohammad, Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet, 10.1152/ajpendo.00229.2010
  51. Kimura Ikuo, Ozawa Kentaro, Inoue Daisuke, Imamura Takeshi, Kimura Kumi, Maeda Takeshi, Terasawa Kazuya, Kashihara Daiji, Hirano Kanako, Tani Taeko, Takahashi Tomoyuki, Miyauchi Satoshi, Shioi Go, Inoue Hiroshi, Tsujimoto Gozoh, The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43, 10.1038/ncomms2852
  52. Sun Bo, Jia Yimin, Hong Jian, Sun Qinwei, Gao Shixing, Hu Yun, Zhao Nannan, Zhao Ruqian, Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation, 10.1021/acs.jafc.8b01189
  53. Fu Zidong Donna, Cui Julia Yue, Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites, 10.1007/s40495-017-0087-0
  54. Chávez-Talavera Oscar, Tailleux Anne, Lefebvre Philippe, Staels Bart, Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease, 10.1053/j.gastro.2017.01.055
  55. Legry Vanessa, Francque Sven, Haas Joel T, Verrijken An, Caron Sandrine, Chávez-Talavera Oscar, Vallez Emmanuelle, Vonghia Luisa, Dirinck Eveline, Verhaegen Ann, Kouach Mostafa, Lestavel Sophie, Lefebvre Philippe, Van Gaal Luc, Tailleux Anne, Paumelle Réjane, Staels Bart, Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects, 10.1210/jc.2017-01397
  56. Wikoff W. R., Anfora A. T., Liu J., Schultz P. G., Lesley S. A., Peters E. C., Siuzdak G., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites, 10.1073/pnas.0812874106
  57. Zheng Xiaojiao, Xie Guoxiang, Zhao Aihua, Zhao Linjing, Yao Chun, Chiu Norman H. L., Zhou Zhanxiang, Bao Yuqian, Jia Weiping, Nicholson Jeremy K., Jia Wei, The Footprints of Gut Microbial–Mammalian Co-Metabolism, 10.1021/pr2007945
  58. Agus Allison, Planchais Julien, Sokol Harry, Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease, 10.1016/j.chom.2018.05.003
  59. Roager Henrik M., Licht Tine R., Microbial tryptophan catabolites in health and disease, 10.1038/s41467-018-05470-4
  60. Jin U.-H., Lee S.-O., Sridharan G., Lee K., Davidson L. A., Jayaraman A., Chapkin R. S., Alaniz R., Safe S., Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities, 10.1124/mol.113.091165
  61. Chimerel Catalin, Emery Edward, Summers David K., Keyser Ulrich, Gribble Fiona M., Reimann Frank, Bacterial Metabolite Indole Modulates Incretin Secretion from Intestinal Enteroendocrine L Cells, 10.1016/j.celrep.2014.10.032
  62. Banoglu Erden, Jha Gautam G., King Roberta S., Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate, 10.1007/bf03226377
  63. Banoglu E., King R. S., Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate, 10.1007/bf03190428
  64. Beaumont Martin, Neyrinck Audrey M., Olivares Marta, Rodriguez Julie, de Rocca Serra Audrey, Roumain Martin, Bindels Laure B., Cani Patrice D., Evenepoel Pieter, Muccioli Giulio G., Demoulin Jean-Baptiste, Delzenne Nathalie M., The gut microbiota metabolite indole alleviates liver inflammation in mice, 10.1096/fj.201800544
  65. Natividad Jane M., Agus Allison, Planchais Julien, Lamas Bruno, Jarry Anne Charlotte, Martin Rebeca, Michel Marie-Laure, Chong-Nguyen Caroline, Roussel Ronan, Straube Marjolene, Jegou Sarah, McQuitty Claire, Le Gall Maude, da Costa Gregory, Lecornet Emmanuelle, Michaudel Chloé, Modoux Morgane, Glodt Jeremy, Bridonneau Chantal, Sovran Bruno, Dupraz Louise, Bado Andre, Richard Mathias L., Langella Philippe, Hansel Boris, Launay Jean-Marie, Xavier Ramnik J., Duboc Henri, Sokol Harry, Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome, 10.1016/j.cmet.2018.07.001
  66. Russell Wendy R., Duncan Sylvia H., Scobbie Lorraine, Duncan Gary, Cantlay Louise, Calder A. Graham, Anderson Susan E., Flint Harry J., Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein, 10.1002/mnfr.201200594
  67. Windey Karen, De Preter Vicky, Verbeke Kristin, Relevance of protein fermentation to gut health, 10.1002/mnfr.201100542
  68. Andriamihaja Mireille, Lan Annaïg, Beaumont Martin, Audebert Marc, Wong Ximena, Yamada Kana, Yin Yulong, Tomé Daniel, Carrasco-Pozo Catalina, Gotteland Martin, Kong Xiangfeng, Blachier François, The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells, 10.1016/j.freeradbiomed.2015.04.004
  69. Beaumont Martin, Portune Kevin Joseph, Steuer Nils, Lan Annaïg, Cerrudo Victor, Audebert Marc, Dumont Florent, Mancano Giulia, Khodorova Nadezda, Andriamihaja Mireille, Airinei Gheorghe, Tomé Daniel, Benamouzig Robert, Davila Anne-Marie, Claus Sandrine Paule, Sanz Yolanda, Blachier François, Quantity and source of dietary protein influence metabolite production by gut microbiota and rectal mucosa gene expression: a randomized, parallel, double-blind trial in overweight humans, 10.3945/ajcn.117.158816
  70. Russell Wendy R, Gratz Silvia W, Duncan Sylvia H, Holtrop Grietje, Ince Jennifer, Scobbie Lorraine, Duncan Garry, Johnstone Alexandra M, Lobley Gerald E, Wallace R John, Duthie Garry G, Flint Harry J, High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health, 10.3945/ajcn.110.002188
  71. Hill Colin, Guarner Francisco, Reid Gregor, Gibson Glenn R., Merenstein Daniel J., Pot Bruno, Morelli Lorenzo, Canani Roberto Berni, Flint Harry J., Salminen Seppo, Calder Philip C., Sanders Mary Ellen, The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic : Expert consensus document, 10.1038/nrgastro.2014.66
  72. Nat Rev Gastroenterol Hepatol, 14, 491 (2017)
  73. Gibson Glenn R., Roberfroid Marcel B., Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics, 10.1093/jn/125.6.1401
  74. Loman Brett R, Hernández-Saavedra Diego, An Ruopeng, Rector R Scott, Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis, 10.1093/nutrit/nuy031
  75. Euroasian J Hepatogastroenterol, 7, 130 (2017)
  76. Eur Rev Med Pharmacol Sci, 15, 1090 (2011)
  77. Ann Hepatol, 12, 256 (2013)
  78. Alisi A., Bedogni G., Baviera G., Giorgio V., Porro E., Paris C., Giammaria P., Reali L., Anania F., Nobili V., Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis, 10.1111/apt.12758
  79. Bindels Laure B., Delzenne Nathalie M., Cani Patrice D., Walter Jens, Towards a more comprehensive concept for prebiotics, 10.1038/nrgastro.2015.47
  80. Burton-Freeman Britt, Postprandial metabolic events and fruit-derived phenolics: a review of the science, 10.1017/s0007114510003909
  81. Delzenne Nathalie M., Cani Patrice D., Everard Amandine, Neyrinck Audrey M., Bindels Laure B., Gut microorganisms as promising targets for the management of type 2 diabetes, 10.1007/s00125-015-3712-7
  82. Catry Emilie, Bindels Laure B, Tailleux Anne, Lestavel Sophie, Neyrinck Audrey M, Goossens Jean-François, Lobysheva Irina, Plovier Hubert, Essaghir Ahmed, Demoulin Jean-Baptiste, Bouzin Caroline, Pachikian Barbara D, Cani Patrice D, Staels Bart, Dessy Chantal, Delzenne Nathalie M, Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction, 10.1136/gutjnl-2016-313316
  83. Mokhtari Zeinab, Gibson Deanna L, Hekmatdoost Azita, Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet, 10.3945/an.116.013151
  84. Parnell Jill A., Raman Maitreyi, Rioux Kevin P., Reimer Raylene A., The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance, 10.1111/j.1478-3231.2011.02730.x
  85. Dewulf Evelyne M, Cani Patrice D, Claus Sandrine P, Fuentes Susana, Puylaert Philippe GB, Neyrinck Audrey M, Bindels Laure B, de Vos Willem M, Gibson Glenn R, Thissen Jean-Paul, Delzenne Nathalie M, Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women, 10.1136/gutjnl-2012-303304
  86. Daubioul C A, Horsmans Y, Lambert P, Danse E, Delzenne N M, Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study, 10.1038/sj.ejcn.1602127
  87. Kellow Nicole J., Coughlan Melinda T., Reid Christopher M., Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials, 10.1017/s0007114513003607
  88. Parnell Jill A., Klancic Teja, Reimer Raylene A., Oligofructose decreases serum lipopolysaccharide and plasminogen activator inhibitor-1 in adults with overweight/obesity : Oligofructose and Inflammation in Obesity, 10.1002/oby.21763
  89. Letexier Dominique, Diraison Frédérique, Beylot Michel, Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans, 10.1093/ajcn/77.3.559
  90. Lambert Jennifer E., Parnell Jill A., Eksteen Bertus, Raman Maitreyi, Bomhof Marc R., Rioux Kevin P., Madsen Karen L., Reimer Raylene A., Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol, 10.1186/s12876-015-0400-5
  91. Bakhshimoghaddam Farnush, Shateri Kamran, Sina Morad, Hashemian Maryam, Alizadeh Mohammad, Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial, 10.1093/jn/nxy088
  92. Malaguarnera Michele, Vacante Marco, Antic Tijana, Giordano Maria, Chisari Giuseppe, Acquaviva Rosaria, Mastrojeni Silvana, Malaguarnera Giulia, Mistretta Antonio, Li Volti Giovanni, Galvano Fabio, Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis, 10.1007/s10620-011-1887-4
  93. Ferolla Silvia, Couto Cláudia, Costa-Silva Luciana, Armiliato Geyza, Pereira Cristiano, Martins Flaviano, Ferrari Maria, Vilela Eduardo, Torres Henrique, Cunha Aloísio, Ferrari Teresa, Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis, 10.3390/nu8070397
  94. Scorletti Eleonora, Afolabi Paul R., Miles Elizabeth A., Smith Debbie E., Almehmadi Amal, Alshathry Albandri, Moyses Helen E., Clough Geraldine F., Wright Mark, Patel Janisha, Bindels Laure, Delzenne Nathalie M., Calder Philip C., Byrne Christopher D., Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease, 10.1016/j.cct.2018.05.010
  95. Vrieze Anne, Van Nood Els, Holleman Frits, Salojärvi Jarkko, Kootte Ruud S., Bartelsman Joep F.W.M., Dallinga–Thie Geesje M., Ackermans Mariette T., Serlie Mireille J., Oozeer Raish, Derrien Muriel, Druesne Anne, Van Hylckama Vlieg Johan E.T., Bloks Vincent W., Groen Albert K., Heilig Hans G.H.J., Zoetendal Erwin G., Stroes Erik S., de Vos Willem M., Hoekstra Joost B.L., Nieuwdorp Max, Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome, 10.1053/j.gastro.2012.06.031
  96. Kootte Ruud S., Levin Evgeni, Salojärvi Jarkko, Smits Loek P., Hartstra Annick V., Udayappan Shanti D., Hermes Gerben, Bouter Kristien E., Koopen Annefleur M., Holst Jens J., Knop Filip K., Blaak Ellen E., Zhao Jing, Smidt Hauke, Harms Amy C., Hankemeijer Thomas, Bergman Jacques J.G.H.M., Romijn Hans A., Schaap Frank G., Olde Damink Steven W.M., Ackermans Mariette T., Dallinga-Thie Geesje M., Zoetendal Erwin, de Vos Willem M., Serlie Mireille J., Stroes Erik S.G., Groen Albert K., Nieuwdorp Max, Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition, 10.1016/j.cmet.2017.09.008
Bibliographic reference Delzenne, Nathalie M. ; Knudsen, Christelle ; Beaumont, Martin ; Rodriguez, Julie ; Neyrinck, Audrey M. ; et. al. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.. In: The Proceedings of the Nutrition Society, Vol. 78, no. 3, p. 319-328 (2019)
Permanent URL http://hdl.handle.net/2078.1/212946